Top compounds associated with response to LMBRD1


Feature Type Standardized
Nominal ANOVA
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.063 0.04
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.04
mRNA KIN001-270 GDSC1000 pan-cancer AAC -0.069 0.04
mRNA lenalidomide FIMM pan-cancer AAC -0.35 0.04
mRNA Bryostatin 1 GDSC1000 pan-cancer AAC 0.071 0.04
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.04
mRNA Panobinostat CTRPv2 pan-cancer AAC 0.068 0.04
mRNA methylstat CTRPv2 pan-cancer AAC 0.084 0.04
mRNA Midostaurin GDSC1000 pan-cancer AAC -0.07 0.04
mRNA PDMP CTRPv2 pan-cancer AAC 0.076 0.04
Download CSV